ERBB2 and neoplasm: For example, it was found that circulating breast cancer cells (that are likely relatively sparse) are ErbB2-positive in a substantial number of cases while primary tumor masses (in which tumor cell density is likely higher than that in case of the circulating tumor cells) derived from the same patients are often ErbB2-negative [46].